Cutting edge: NKG2D signaling enhances nk cell responses but alone is insufficient to drive expansion during mouse cytomegalovirus infection

Journal of Immunology

Volumn 199, Issue 5, 2017, Pages 1567-1571

  Nabekura, Tsukasa ^a,b,c   Gotthardt, Dagmar ^a,b   Niizuma, Kouta ^a,c   Trsan, Tihana ^d   Jenus, Tina ^d   Jonjic, Stipan ^d   Lanier, Lewis L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY   (United States)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

HCST PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; KLRA8 PROTEIN, MOUSE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROBP PROTEIN, MOUSE;

ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MUROMEGALOVIRUS; NATURAL KILLER CELL; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; HERPESVIRIDAE INFECTIONS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 85027998666     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1700799     Document Type: Article

References (45)

1. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
2. Lanier, L. L. 2003. Natural killer cell receptor signaling. Curr. Opin. Immunol. 15: 308-314.
3. Min-Oo, G., Y. Kamimura, D. W. Hendricks, T. Nabekura, and L. L. Lanier. 2013. Natural killer cells: walking three paths down memory lane. Trends Immunol. 34: 251-258.
4. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457: 557-561.
5. Nabekura, T., and L. L. Lanier. 2014. Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation. J. Exp. Med. 211: 2455-2465.
6. Nabekura, T., and L. L. Lanier. 2016. Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection. J. Exp. Med. 213: 2745-2758.
7. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
8. Nabekura, T.,M. Kanaya, A. Shibuya, G. Fu, N. R. Gascoigne, and L. L. Lanier. 2014. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity 40: 225-234.
9. Sun, J. C., S. Madera, N. A. Bezman, J. N. Beilke, M. H. Kaplan, and L. L. Lanier. 2012. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J. Exp. Med. 209: 947-954.
10. Madera, S., and J. C. Sun. 2015. Cutting edge: stage-specific requirement of IL-18 for antiviral NK cell expansion. J. Immunol. 194: 1408-1412.
11. Nabekura, T., J. P. Girard, and L. L. Lanier. 2015. IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection. J. Immunol. 194: 5948-5952.
12. Lanier, L. L. 2009. DAP10-and DAP12-associated receptors in innate immunity. Immunol. Rev. 227: 150-160.
13. Orr, M. T., J. C. Sun, D. G. Hesslein, H. Arase, J. H. Phillips, T. Takai, and L. L. Lanier. 2009. Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J. Exp. Med. 206: 807-817.
14. Wu, J., Y. Song, A. B. Bakker, S. Bauer, T. Spies, L. L. Lanier, and J. H. Phillips. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285: 730-732.
15. Jamieson, A. M., A. Diefenbach, C. W. McMahon, N. Xiong, J. R. Carlyle, and D. H. Raulet. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17: 19-29.
16. Champsaur, M., and L. L. Lanier. 2010. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 235: 267-285.
17. Raulet, D. H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3: 781-790.
18. Houchins, J. P., T. Yabe, C. McSherry, and F. H. Bach. 1991. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173: 1017-1020.
19. Diefenbach, A., E. Tomasello, M. Lucas, A. M. Jamieson, J. K. Hsia, E. Vivier, and D. H. Raulet. 2002. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3: 1142-1149.
20. Gilfillan, S., E. L. Ho, M. Cella, W. M. Yokoyama, and M. Colonna. 2002. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3: 1150-1155.
21. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
22. Billadeau, D. D., J. L. Upshaw, R. A. Schoon, C. J. Dick, and P. J. Leibson. 2003. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 4: 557-564.
23. Zompi, S., J. A. Hamerman, K. Ogasawara, E. Schweighoffer, V. L. Tybulewicz, J. P. Di Santo, L. L. Lanier, and F. Colucci. 2003. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat. Immunol. 4: 565-572.
24. Fodil-Cornu, N., S. H. Lee, S. Belanger, A. P. Makrigiannis, C. A. Biron, R. M. Buller, and S. M. Vidal. 2008. Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J. Immunol. 181: 6394-6405.
25. Inui, M., Y. Kikuchi, N. Aoki, S. Endo, T. Maeda, A. Sugahara-Tobinai, S. Fujimura, A. Nakamura, A. Kumanogoh, M. Colonna, and T. Takai. 2009. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc. Natl. Acad. Sci. USA 106: 4816-4821.
26. Hyka-Nouspikel, N., and J. H. Phillips. 2006. Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity. Immunol. Rev. 214: 106-117.
27. Bakker, A. B., R.M. Hoek, A. Cerwenka, B. Blom, L. Lucian, T. McNeil, R.Murray, L. H. Phillips, J. D. Sedgwick, and L. L. Lanier. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13: 345-353.
28. Wagner, M., S. Jonjic, U. H. Koszinowski, and M. Messerle. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73: 7056-7060.
29. Krmpotić, A., D.H. Busch, I. Bubić, F.Gebhardt,H. Hengel, M.Hasan, A. A. Scalzo, U. H. Koszinowski, and S. Jonjić. 2002. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat. Immunol. 3: 529-535.
30. Slavuljica, I., A. Busche, M. Babić, M. Mitrović, I. Ga?sparović, D. Cekinović, E. Markova Car, E. Pernjak Pugel, A. Ciković, V. J. Lisnić, et al. 2010. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J. Clin. Invest. 120: 4532-4545.
31. Bubić, I., M. Wagner, A. Krmpotić, T. Saulig, S. Kim, W. M. Yokoyama, S. Jonjić, and U. H. Koszinowski. 2004. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78: 7536-7544.
32. Brune, W., H. Hengel, and U. H. Koszinowski. 2001. A mouse model for cytomegalovirus infection. Curr. Protoc. Immunol. Chapter 19: Unit 19.17.
33. Lodoen, M., K. Ogasawara, J. A. Hamerman, H. Arase, J. P. Houchins, E. S. Mocarski, and L. L. Lanier. 2003. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197: 1245-1253.
34. Arapovic, J., T. Lenac, R. Antulov, B. Polic, Z. Ruzsics, L. N. Carayannopoulos, U. H. Koszinowski, A. Krmpotic, and S. Jonjic. 2009. Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J. Virol. 83: 8198-8207.
35. Ogasawara, K., J. A. Hamerman, H. Hsin, S. Chikuma, H. Bour-Jordan, T. Chen, T. Pertel, C. Carnaud, J. A. Bluestone, and L. L. Lanier. 2003. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18: 41-51.
36. Zafirova, B., S. Mandarić, R. Antulov, A. Krmpotić, H. Jonsson, W. M. Yokoyama, S. Jonjić, and B. Polić. 2009. Altered NK cell development and enhanced NK cellmediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 31: 270-282.
37. Lanier, L. L. 2015. NKG2D receptor and its ligands in host defense. Cancer Immunol. Res. 3: 575-582.
38. Sjölin, H., E. Tomasello, M. Mousavi-Jazi, A. Bartolazzi, K. Kärre, E. Vivier, and C. Cerboni. 2002. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195: 825-834.
39. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2: 255-260.
40. Maasho, K., J. Opoku-Anane, A. I. Marusina, J. E. Coligan, and F. Borrego. 2005. NKG2D is a costimulatory receptor for human naive CD8+ T cells. J. Immunol. 174: 4480-4484.
41. Kavazović, I., M. Lenartić, V. Jelencić, S. Jurković, N. A. W. Lemmermann, S. Jonjić, B. Polić, and F. M. Wensveen. 2017. NKG2D stimulation of CD8(+) T cells during priming promotes their capacity to produce cytokines in response to viral infection in mice. Eur. J. Immunol. 47: 1123-1135.
42. Tomić, A., P. R. Varanasi, M. Golemac, S. Malić, P. Riese, E. M. Borst, E. Mischak-Weissinger, C. A. Guzmán, A. Krmpotić, S. Jonjić, and M. Messerle. 2016. Activation of innate and adaptive immunity by a recombinant human cytomegalovirus strain expressing an NKG2D ligand. PLoS Pathog. 12: e1006015.
43. Lanier, L. L., and A. B. Bakker. 2000. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol. Today 21: 611-614.
44. Lanier, L. L., B. C. Corliss, J. Wu, C. Leong, and J. H. Phillips. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703-707.
45. Straus, D. B., and A. Weiss. 1993. The CD3 chains of the T cell antigen receptor associate with the ZAP-70 tyrosine kinase and are tyrosine phosphorylated after receptor stimulation. J. Exp. Med. 178: 1523-1530.